From: Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study
Covariates | Overall (%) | Grade 1 (%) | Grade 2 (%) | Grade 3 (%) | P |
---|---|---|---|---|---|
 | N = 139 | N = 83 | N = 20 | N = 10 |  |
Age | Â | Â | Â | Â | 0.06 |
≥ 65 | 44 (32) | 23 (28) | 11 (55) | 2 (20) |  |
Sex | Â | Â | Â | Â | 0.35 |
Female | 61 (44) | 41 (49) | 7 (35) | 3 (30) | Â |
pT Stagea | Â | Â | Â | Â | 0.003 |
X | 18 (15) | 9 (12) | 0 (0) | 2 (50) | Â |
pT1 | 72 (62) | 52 (68) | 9 (60) | 1 (25) | Â |
pT2 | 18 (15) | 13 (17) | 1 (7) | 1 (25) | Â |
pT3 | 9 (8) | 3 (4) | 5 (33) | 0 (0) | Â |
pT4 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | Â |
pN Stagea | Â | Â | Â | Â | 0.002 |
X | 96 (85) | 66 (90) | 7 (50) | 4 (100) | Â |
pN0 | 10 (9) | 6 (8) | 2 (14) | 0 (0) | Â |
pN1 | 5 (4) | 1 (1) | 4 (29) | 0 (0) | Â |
pN2 | 2 (2) | 0 (0) | 1 (7) | 0 (0) | Â |
Metastatic disease at diagnosis |  |  |  | < 0.001 | |
Yes | 22 (16) | 1 (1) | 9 (45) | 8 (80) | Â |
Diametera | Â | Â | Â | Â | 0.23 |
< 10 mm | 81 (90) | 57 (92) | 10 (77) | 1 (100) |  |
10–20 mm | 8 (9) | 5 (8) | 3 (23) | 0 (0) |  |
≥ 20 mm | 1 (1) | 1 (0) | 0 (0) | 0 (0) |  |
LVIa | Â | Â | Â | Â | 0.04 |
Positive | 7 (11) | 3 (6) | 3 (27) | 1 (50) | Â |
Status |  |  |  |  | < 0.001 |
Dead | 27 (19) | 5 (6) | 10 (50) | 9 (90) | Â |
Recurrence | N = 110 | N = 77 | N = 10 | N = 1 | 0.01 |
Yes | 12 (11) | 5 (6) | 4 (40) | 0 (0) | Â |